These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28924485)

  • 1. Hypogonadotropic hypogonadism in human immunodeficiency virus-infected men: uncommonly low testosterone levels.
    Gomes AC; Aragüés JM; Guerra S; Fernandes J; Mascarenhas MR
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28924485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of
    Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
    Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadism in the HIV-infected man.
    Rochira V; Guaraldi G
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):709-30. PubMed ID: 25169563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male acquired hypogonadotropic hypogonadism: diagnosis and treatment.
    Salenave S; Trabado S; Maione L; Brailly-Tabard S; Young J
    Ann Endocrinol (Paris); 2012 Apr; 73(2):141-6. PubMed ID: 22541999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I; Lubina A; Gorfine M; Ilany J
    J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility.
    Nachtigall LB; Boepple PA; Pralong FP; Crowley WF
    N Engl J Med; 1997 Feb; 336(6):410-5. PubMed ID: 9010147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
    Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
    J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch to restoration therapy in a testosterone treated central hypogonadism with erythrocytosis.
    Cangiano B; Cacciatore C; Persani L; Bonomi M
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28721216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy.
    Gomes AR; Souteiro P; Silva CG; Sousa-Pinto B; Almeida F; Sarmento A; Carvalho D; Freitas P
    BMC Infect Dis; 2016 Nov; 16(1):628. PubMed ID: 27809804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormone Profile in Human Immunodeficiency Virus-Infected Men and It's Correlation with CD4 Cell Counts.
    Aggarwal J; Taneja RS; Gupta PK; Wali M; Chitkara A; Jamal A
    Indian J Endocrinol Metab; 2018; 22(3):328-334. PubMed ID: 30090723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.
    Rietschel P; Corcoran C; Stanley T; Basgoz N; Klibanski A; Grinspoon S
    Clin Infect Dis; 2000 Nov; 31(5):1240-4. PubMed ID: 11073758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study.
    Rochira V; Diazzi C; Santi D; Brigante G; Ansaloni A; Decaroli MC; De Vincentis S; Stentarelli C; Zona S; Guaraldi G
    Andrology; 2015 Mar; 3(2):298-308. PubMed ID: 25704864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence, patterns & predictors of hypogonadism in patients with HIV infection in India.
    Dutta D; Sharma LK; Sharma N; Gadpayle AK; Anand A; Gaurav K; Gupta A; Poondla Y; Kulshreshtha B
    Indian J Med Res; 2017 Jun; 145(6):804-814. PubMed ID: 29067983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PITUITARY IMAGING BY MRI AND ITS CORRELATION WITH BIOCHEMICAL PARAMETERS IN THE EVALUATION OF MEN WITH HYPOGONADOTROPIC HYPOGONADISM.
    Das G; Surya A; Okosieme O; Vali A; Tennant BP; Geen J; Abusahmin H
    Endocr Pract; 2019 Sep; 25(9):926-934. PubMed ID: 31170366
    [No Abstract]   [Full Text] [Related]  

  • 17. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems.
    Bhatia R; Murphy AB; Raper JL; Chamie G; Kitahata MM; Drozd DR; Mayer K; Napravnik S; Moore R; Achenbach C;
    AIDS; 2015 Jan; 29(1):77-81. PubMed ID: 25387318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone.
    Wasserman P; Segal-Maurer S; Rubin D
    J Sex Med; 2008 Jan; 5(1):241-7. PubMed ID: 17961146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Disorders and Male Hypogonadotropic Hypogonadism.
    Pivonello R; Menafra D; Riccio E; Garifalos F; Mazzella M; de Angelis C; Colao A
    Front Endocrinol (Lausanne); 2019; 10():345. PubMed ID: 31402895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMBINED TREATMENT WITH FOCUSED LOW-INTENSITY SHOCK-WAVE THERAPY AND ANDROGEN-STIMULATION THERAPY IN MEN WITH CORPORAL VENO-OCCLUSIVE ERECTILE DYSFUNCTION ON THE BACKGROUND OF HYPOGONADOTROPIC HYPOGONADISM.
    Zasieda Y
    Georgian Med News; 2020 Oct; (307):49-53. PubMed ID: 33270577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.